A carregar...
Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection
BACKGROUND/AIMS: The Social Security System of our country reimburses only paritaprevir, ritonavir, ombitasvir, and dasabuvir (PrOD) regime in treatment-naive patients with hepatitis C regardless of kidney disease. Most of our renal transplant (RT) recipients were treated with PrOD. The aim of the p...
Na minha lista:
| Publicado no: | Turk J Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Turkish Society of Gastroenterology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6699569/ https://ncbi.nlm.nih.gov/pubmed/31418413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2019.18833 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|